Modulation of the FGF14:FGF14 Homodimer Interaction Through Short Peptide Fragments

E-ISSN： 1996-3181|13|9|1559-1570

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.9, 2014-11, pp. : 1559-1570

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In Vivo Anti-Tumor Effect of Expressing p14ARF-TAT Using a FGF2-Targeted Cationic Lipid Vector

By Niu Guoqin Driessen Wouter Sullivan Sean Hughes Jeffrey

Pharmaceutical Research, Vol. 28, Iss. 4, 2011-04 ,pp. : 720-730

Springer Publishing Company

Access to resources Recommend Favorite

Effect of bFGF on invasion of ovarian cancer cells through the regulation of Ets-1 and urokinase-type plasminogen activator

By Li Ting Jiang Sen

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 48, Iss. 2, 2010-02 ,pp. : 161-165

Informa Healthcare

Access to resources Recommend Favorite

FGF10 and FGF21 as Regulators in Adipocyte Development and Metabolism

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 4, 2011-12 ,pp. : 302-309

Bentham Science Publishers

Access to resources Recommend Favorite

rFGF-2: therapeutic angiogenesis in intermittent claudication

Inpharma, Vol. 1, Iss. 1343, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Regulation of FGF-1 and FGF-2 gene expression in primary culture of rat astrocytes following beta adrenergic receptor activation

By Molteni R. Fumagalli F. Lovati E. Racagni G. Riva M.A.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 412-412

Elsevier

Access to resources Recommend Favorite